• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Maspin通过位点外-位点外相互作用与尿激酶型和组织型纤溶酶原激活剂结合。

Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions.

作者信息

Al-Ayyoubi Maher, Schwartz Bradford S, Gettins Peter G W

机构信息

Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60607, USA.

出版信息

J Biol Chem. 2007 Jul 6;282(27):19502-9. doi: 10.1074/jbc.M702445200. Epub 2007 May 16.

DOI:10.1074/jbc.M702445200
PMID:17510061
Abstract

Maspin is a member of the serpin family with a reactive center loop that is incompatible with proteinase inhibition by the serpin conformational change mechanism. Despite this there are reports that maspin might regulate uPA-dependent processes in vivo. Using exogenous and endogenous fluorescence, we demonstrate here that maspin can bind uPA and tPA in both single-chain and double-chain forms, with K(d) values between 300 and 600 nM. Binding is at an exosite on maspin close to, but outside of, the reactive center loop and is therefore insensitive to mutation of Arg(340) within the reactive center loop. The binding site on tPA does not involve the proteinase active site, with the result that maspin can bind to S195A tPA that is already complexed to plasminogen activator inhibitor-1. The ability of maspin to bind these proteinases without involvement of the reactive center loop leaves the latter free to engage in additional, as yet unidentified, maspin-protein interactions that may serve to regulate the properties of the exosite-bound proteinase. This may help to reconcile apparently conflicting studies that demonstrate the importance of the reactive center loop in certain maspin functions, despite the inability of maspin to directly inhibit tPA or uPA catalytic activity in in vitro assays through engagement between its reactive center loop and the active site of the proteinase.

摘要

Maspin是丝氨酸蛋白酶抑制剂(serpin)家族的成员,其反应中心环与通过serpin构象变化机制抑制蛋白酶不相容。尽管如此,有报道称maspin可能在体内调节依赖尿激酶型纤溶酶原激活物(uPA)的过程。利用外源性和内源性荧光,我们在此证明maspin可以结合单链和双链形式的uPA和组织型纤溶酶原激活物(tPA),解离常数(K(d))值在300至600 nM之间。结合发生在maspin上靠近反应中心环但在其外部的一个别构部位,因此对反应中心环内的精氨酸(Arg(340))突变不敏感。tPA上的结合位点不涉及蛋白酶活性位点,结果maspin可以结合已经与纤溶酶原激活物抑制剂-1形成复合物的S195A tPA。maspin在不涉及反应中心环的情况下结合这些蛋白酶的能力,使得后者能够自由地参与其他尚未确定的maspin-蛋白质相互作用,这些相互作用可能有助于调节别构部位结合的蛋白酶的特性。这可能有助于调和一些明显相互矛盾的研究结果,这些研究表明反应中心环在某些maspin功能中很重要,尽管在体外实验中maspin无法通过其反应中心环与蛋白酶活性位点的结合直接抑制tPA或uPA的催化活性。

相似文献

1
Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions.Maspin通过位点外-位点外相互作用与尿激酶型和组织型纤溶酶原激活剂结合。
J Biol Chem. 2007 Jul 6;282(27):19502-9. doi: 10.1074/jbc.M702445200. Epub 2007 May 16.
2
Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂-1与组织纤溶酶原激活物及胰蛋白酶反应中米氏复合物的解离、酰化及构象变化步骤
Biochemistry. 2001 Oct 2;40(39):11742-56. doi: 10.1021/bi0107290.
3
The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.前列腺癌DU145细胞表面介导了乳腺丝抑蛋白对尿激酶型纤溶酶原激活剂的抑制作用。
Cancer Res. 2000 Sep 1;60(17):4771-8.
4
The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition.纤溶酶原激活物抑制剂-1的外部位点残基对蛋白酶抑制作用的贡献。
J Biol Chem. 2004 Jan 30;279(5):3643-50. doi: 10.1074/jbc.M310601200. Epub 2003 Oct 31.
5
A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.丝氨酸蛋白酶抑制剂诱导尿激酶型纤溶酶原激活剂产生广泛的蛋白水解敏感性,这表明在丝氨酸蛋白酶抑制剂的抑制机制中,蛋白酶底物结合口袋和氧阴离子洞发生了扭曲。
Eur J Biochem. 2001 Feb;268(3):673-85. doi: 10.1046/j.1432-1327.2001.01921.x.
6
The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.牛痘病毒丝氨酸蛋白酶抑制剂SPI-3与尿激酶型和组织型纤溶酶原激活剂及纤溶酶结合并抑制它们。
Virology. 2000 Jul 5;272(2):267-80. doi: 10.1006/viro.2000.0377.
7
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.组织型纤溶酶原激活剂是肿瘤抑制基因maspin的一个靶点。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):499-504. doi: 10.1073/pnas.95.2.499.
8
Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.乳腺丝抑蛋白通过与尿激酶型纤溶酶原激活剂/尿激酶型纤溶酶原激活剂受体系统的新型相互作用来延缓细胞脱离。
Cancer Res. 2006 Apr 15;66(8):4173-81. doi: 10.1158/0008-5472.CAN-05-3514.
9
Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.活性中心环构象和动力学变化揭示了纤溶酶原激活物抑制剂-1(PAI-1)与纤溶酶原激活物及玻连蛋白形成的不同结合复合物。
Protein Sci. 2016 Feb;25(2):499-510. doi: 10.1002/pro.2841. Epub 2015 Dec 2.
10
Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.Maspin 增加与角膜成纤维细胞和肌成纤维细胞相关的细胞外纤溶酶原激活物活性。
Exp Eye Res. 2011 Nov;93(5):618-27. doi: 10.1016/j.exer.2011.07.008. Epub 2011 Jul 27.

引用本文的文献

1
The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation.C1 酯酶抑制剂与 C1s 的米氏复合体的晶体结构揭示了补体调控的新见解。
J Immunol. 2024 Sep 1;213(5):718-729. doi: 10.4049/jimmunol.2400194.
2
Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity.maspin在前列腺肿瘤细胞中的表达可避免干性并区分药物敏感性。
Cancer Res. 2015 Sep 15;75(18):3970-9. doi: 10.1158/0008-5472.CAN-15-0234. Epub 2015 Jul 24.
3
Internalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics.
多种内吞途径和溶酶体处理的内化作用影响基于 maspin 的治疗方法。
Mol Cancer Res. 2014 Oct;12(10):1480-91. doi: 10.1158/1541-7786.MCR-14-0067. Epub 2014 Sep 25.
4
Maspin is not required for embryonic development or tumour suppression.乳腺丝抑蛋白对于胚胎发育或肿瘤抑制并非必需。
Nat Commun. 2014;5:3164. doi: 10.1038/ncomms4164.
5
Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.Maspin 增加与角膜成纤维细胞和肌成纤维细胞相关的细胞外纤溶酶原激活物活性。
Exp Eye Res. 2011 Nov;93(5):618-27. doi: 10.1016/j.exer.2011.07.008. Epub 2011 Jul 27.
6
Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesion.Maspin,即纤溶酶原激活物系统和整合素β1 之间的分子桥,促进细胞黏附。
J Biol Chem. 2011 Jul 15;286(28):24599-607. doi: 10.1074/jbc.M111.235788. Epub 2011 May 23.
7
Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.骨桥蛋白凝血酶裂解结构域缺失介导乳腺癌细胞黏附、蛋白水解活性、致瘤性和转移。
BMC Cancer. 2011 Jan 19;11:25. doi: 10.1186/1471-2407-11-25.
8
G-helix of maspin mediates effects on cell migration and adhesion.Maspin 的 G 螺旋结构介导了对细胞迁移和黏附的影响。
J Biol Chem. 2010 Nov 19;285(47):36285-92. doi: 10.1074/jbc.M110.177253. Epub 2010 Sep 13.
9
Exosite determinants of serpin specificity.丝氨酸蛋白酶抑制剂特异性的外部决定因素。
J Biol Chem. 2009 Jul 31;284(31):20441-5. doi: 10.1074/jbc.R800064200. Epub 2009 Apr 28.
10
Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate.乳腺丝抑蛋白肿瘤抑制基因单倍体不足会导致前列腺增生性病变。
Cancer Res. 2008 Jul 1;68(13):5143-51. doi: 10.1158/0008-5472.CAN-08-0163.